Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior

Cell Transplantation

Volumn 20, Issue 8, 2011, Pages 1299-1313

  Morosetti, Roberta ^a,b   Gidaro, Teresa ^a   Broccolini, Aldobrando ^a,b   Gliubizzi, Carla ^a,b   Sancricca, Cristina ^a   Tonali, Pietro Attilio ^a,b   Ricci, Enzo ^a,b   Mirabella, Massimiliano ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Facioscapulohumeral muscular dystrophy (FSHD); Mesoangioblasts; Myogenic stem cells; Transplantation

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; DISEASE SEVERITY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEMANGIOBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUSCLE BIOPSY; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; THERAPY EFFECT;

MUS;

EID: 84930480377     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X546571     Document Type: Article

References (26)

1. Agresti, A.; Bianchi, M. E. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13(2):170-178; 2003.
2. Benabdallah, B. F.; Bouchentouf, M.; Rousseau, J.; Tremblay, J. P. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Cell Transplant. 18(7):709-718; 2009.
3. Boldrin, L.; Malerba, A.; Vitiello, L.; Cimetta, E.; Piccoli, M.; Messina, C.; Gamba, P. G.; Elvassore, N.; De Coppi, P. Efficient delivery of human single fiber-derived muscle precursor cells via biocompatible scaffold. Cell Transplant. 17(5):577-584; 2008.
4. Bonaldi, T.; Talamo, F.; Scaffidi, P.; Ferrera, D.; Porto, A.; Bachi, A.; Rubartelli, A.; Agresti, A.; Bianchi, M. E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22(20):5551-5560; 2003.
5. Degryse, B.; Bonaldi, T.; Scaffidi, P.; Muller, S.; Resnati, M.; Sanvito, F.; Arrigoni, G.; Bianchi, M. E. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152(6):1197-1206; 2001.
6. Dellavalle, A.; Sampaolesi, M.; Tonlorenzi, R.; Taglia- fico, E.; Sacchetti, B.; Perani, L.; Innocenzi, A.; Galvez, B. G.; Messina, G.; Morosetti, R.; Li, S.; Belicchi, M.; Peretti, G.; Chamberlain, J. S.; Wright, W. E.; Torrente, Y.; Ferrari, S.; Bianco, P.; Cossu, G. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9(3):255-267; 2007.
7. Galvez, B. G.; Sampaolesi, M.; Brunelli, S.; Covarello, D.; Gavina, M.; Rossi, B.; Constantin, G.; Torrente, Y.; Cossu, G. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 174(2):231-243; 2006.
8. Lemmers, R. J.; van der Vliet, P. J.; Klooster, R.; Sacconi, S.; Camano, P.; Dauwerse, J. G.; Snider, L.; Straasheijm, K. R.; Jan van Ommen, G.; Padberg, G. W.; Miller, D. G.; Tapscott, S. J.; Tawil, R.; Frants, R. R.; van der Maarel, S. M. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329(5999):1650-1653; 2010.
9. Liu, Z.; Wu, Y.; Chen, B. G. Myoblast therapy: From bench to bedside. Cell Transplant. 15(6):455-462; 2006.
10. Lolmede, K.; Campana, L.; Vezzoli, M.; Bosurgi, L.; Tonlorenzi, R.; Clementi, E.; Bianchi, M. E.; Cossu, G.; Manfredi, A. A.; Brunelli, S.; Rovere-Querini, P. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1-and MMP-9-dependent pathways. J. Leukoc. Biol. 85(5):779-787; 2009.
11. Lunt, P. W.; Harper, P. S. Genetic counselling in facioscapulohumeral muscular dystrophy. J. Med. Genet. 28(10):655-664; 1991.
12. Macaione, V.; Aguennouz, M.; Rodolico, C.; Mazzeo, A.; Patti, A.; Cannistraci, E.; Colantone, L.; Di Giorgio, R. M.; De Luca, G.; Vita, G. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Acta Neurol. Scand. 115(2): 115-121; 2007.
13. Mohle, R.; Moore, M. A.; Nachman, R. L.; Rafii, S. Transendothelial migration of CD34+ and mature hematopoietic cells: An in vitro study using a human bone marrow endothelial cell line. Blood 89(1):72-80; 1997.
14. Morosetti, R.; Mirabella, M.; Gliubizzi, C.; Broccolini, A.; De Angelis, L.; Tagliafico, E.; Sampaolesi, M.; Gidaro, T.; Papacci, M.; Roncaglia, E.; Rutella, S.; Ferrari, S.; Tonali, P. A.; Ricci, E.; Cossu, G. MyoD expression restores defective myogenic differentiation of human mes- oangioblasts from inclusion-body myositis muscle. Proc. Natl. Acad. Sci. USA 103(45):16995-17000; 2006.
15. Morosetti, R.; Mirabella, M.; Gliubizzi, C.; Broccolini, A.; Sancricca, C.; Pescatori, M.; Gidaro, T.; Tasca, G.; Frusci- ante, R.; Tonali, P. A.; Cossu, G.; Ricci, E. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 25(12):3173-3182; 2007.
16. Padberg, J. Facioscapulohumeral disease. MD thesis. Leiden: Leiden University; 1982.
17. Palumbo, R.; Galvez, B. G.; Pusterla, T.; De Marchis, F.; Cossu, G.; Marcu, K. B.; Bianchi, M. E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J. Cell Biol. 179(1):33-40; 2007.
18. Palumbo, R.; Sampaolesi, M.; De Marchis, F.; Tonlorenzi, R.; Colombetti, S.; Mondino, A.; Cossu, G.; Bianchi, M. E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164(3):441-449; 2004.
19. Ricci, E.; Galluzzi, G.; Deidda, G.; Cacurri, S.; Colantoni, L.; Merico, B.; Piazzo, N.; Servidei, S.; Vigneti, E.; Pasceri, V.; Silvestri, G.; Mirabella, M.; Mangiola, F.; Tonali, P.; Felicetti, L. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann. Neurol. 45(6):751-757; 1999.
20. Sampaolesi, M.; Blot, S.; D'Antona, G.; Granger, N.; Tonlorenzi, R.; Innocenzi, A.; Mognol, P.; Thibaud, J. L.; Galvez, B. G.; Barthelemy, I.; Perani, L.; Mantero, S.; Guttinger, M.; Pansarasa, O.; Rinaldi, C.; Cusella De Angelis, M. G.; Torrente, Y.; Bordignon, C.; Bottinelli, R.; Cossu, G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444(7119):574-579; 2006.
21. Sampaolesi, M.; Torrente, Y.; Innocenzi, A.; Tonlorenzi, R.; D'Antona, G.; Pellegrino, M. A.; Barresi, R.; Bresolin, N.; De Angelis, M. G.; Campbell, K. P.; De Angelis, M. G.; Campbell, K. P.; Bottinelli, R.; Cossu, G. Cell ther apy of alpha-sarcoglycan null dystrophic mice through in- tra-arterial delivery of mesoangioblasts. Science 301(5632): 487-492; 2003.
22. Sciorati, C.; Galvez, B. G.; Brunelli, S.; Tagliafico, E.; Ferrari, S.; Cossu, G.; Clementi, E. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci. 119(Pt. 24):5114-5123; 2006.
23. Tupler, R.; Gabellini, D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell. Mol. Life Sci. 61(5): 557-566; 2004.
24. Vauchez, K.; Marolleau, J. P.; Schmid, M.; Khattar, P.; Chapel, A.; Catelain, C.; Lecourt, S.; Larghero, J.; Fiszman, M.; Vilquin, J. T. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol. Ther. 17(11):1948-1958; 2009.
25. Vilquin, J. T.; Marolleau, J. P.; Sacconi, S.; Garcin, I.; Lacassagne, M. N.; Robert, I.; Ternaux, B.; Bouazza, B.; Larghero, J.; Desnuelle, C. Normal growth and regenerating ability of myoblasts from unaffected muscles of facio-scapulohumeral muscular dystrophy patients. Gene Ther. 12(22):1651-1662; 2005.
26. Wang, H.; Bloom, O.; Zhang, M.; Vishnubhakat, J. M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L.; Manogue, K. R.; Faist, E.; Abraham, E.; Andersson, J.; Andersson, U.; Molina, P. E.; Abum- rad, N. N.; Sama, A.; Tracey, K. J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425): 248-251; 1999.